Exploring the anticancer potential of Eleutherine bulbosa: A systematic network pharmacology study on lung cancer

R Mutiah, E Rachmawati - Journal of Advanced Pharmaceutical …, 2024 - journals.lww.com
Chemotherapy application in lung cancer patients has several side effects and shows lower
effectiveness due to chemoresistance. Although Eleutherine bulbosa (Mill.) Urb.(EBE) elicit …

Mechanisms of Herba Epimedii in Lung Cancer Treatment: A Combination of Molecular Docking and Network Pharmacology Analyses

J Zhang - Pharmacognosy Magazine, 2023 - journals.sagepub.com
Introduction Lung cancer (LC) ranks among the most prevalent malignant neoplasms
globally. As a Traditional Chinese medicine (TCM), Herba Epimedii has been commonly …

Anti-lung cancer targets of Radix Paeoniae Rubra and biological molecular mechanism: network pharmacological analyses and experimental validation

Y Ma, G Li, M Yu, K Cao, Q Li, X Sun… - OncoTargets and …, 2021 - Taylor & Francis
Objective To systematically explore the pharmacological mechanism of Radix Paeoniae
Rubra (RPR) against lung cancer (LC). Methods A network pharmacology approach, which …

A Network Pharmacology Approach to Reveal the Underlying Mechanisms of Artemisia annua on the Treatment of Hepatocellular Carcinoma

S Zhang, Z Mo, S Zhang, X Li - … ‐Based Complementary and …, 2021 - Wiley Online Library
Objective. To investigate the potential active ingredients and underlying mechanisms of
Artemisia annua (AA) on the treatment of hepatocellular carcinoma (HCC) based on network …

Interactions of quercetin with receptor tyrosine kinases associated with human lung carcinoma

B Baby, P Antony, R Vijayan - Natural product research, 2018 - Taylor & Francis
Lung cancer is a deadly form of cancer with high morbidity and mortality rates. Deregulated
receptor tyrosine kinases (RTKs) are frequently associated with the formation and …

[PDF][PDF] Network pharmacology prediction and molecular docking analysis on the mechanism of eugenol as a candidate against estrogen receptor-positive breast …

INN Sihombing, A Arsianti - Journal of Pharmacy & Pharmacognosy …, 2024 - jppres.com
Context: Breast cancer therapy currently presents several uncomfortable side effects in
patients, including effects on non-malignant tissues, recurrence, and resistance, which …

Ligand-based virtual screening, molecular docking, QSAR and pharmacophore analysis of quercetin-associated potential novel analogs against epidermal growth …

UD Bommu, KK Konidala, N Pabbaraju… - Journal of Receptors …, 2017 - Taylor & Francis
The present study was to explore expectation and examination of therapeutic potential
quercetin analogs as efficient anticancer agents against human epidermal growth factor …

Molecular mechanism of Rhubarb in the treatment of non-small cell lung cancer based on network pharmacology and molecular docking technology

YR Tan, Y Lu - Molecular Diversity, 2023 - Springer
Non-small cell lung cancer (NSCLC) is one of the leading causes of death in the world.
Rhubarb, a traditional Chinese medicine, has been widely used in the treatment of …

[Retracted] Analysis of the Molecular Mechanism of Evodia rutaecarpa Fruit in the Treatment of Nasopharyngeal Carcinoma Using Network Pharmacology and …

R Xu, X Yang, Y Tao, W Luo, Y Xiong… - Journal of …, 2022 - Wiley Online Library
Background. Nasopharyngeal carcinoma (NPC), a neoplasm of the head and neck, has high
incidence and mortality rates in East and Southeast Asia. Evodia rutaecarpa is a tree native …

The Antiproliferative Effect of Chloroform Fraction of Eleutherine bulbosa (Mill.) Urb. on 2D- and 3D-Human Lung Cancer Cells (A549) Model

NH Zakaria, N Saad, CA Che Abdullah, N Mohd. Esa - Pharmaceuticals, 2023 - mdpi.com
Since lung cancer is the leading cause of cancer-related death worldwide, research is being
conducted to discover anticancer agents as its treatment. Eleutherine bulbosa, a Dayak …